metabolic profiles of RA patients, comparing them to healthy controls. At the study’s outset, RA patients exhibited elevated levels of certain metabolites, including succinate, lysine, mannose, creatine, and 3-Hydroxybutyrate (3-HB), alongside decreased alanine levels. However, following AWS treatment, these metabolic markers began to shift towards the levels observed in healthy individuals, indicating a return to a more balanced metabolic state.
As per the researchers, this study is the first of its kind to clearly demonstrate the clinical efficacy of AWS in managing RA. The intervention not only reduced symptoms but also promoted a metabolic environment conducive to homeostasis, potentially leading to long-term benefits for RA patients.
While these findings are promising, the study’s authors emphasise the need for further research to confirm these preliminary results and to better understand the mechanisms through which AWS exerts its therapeutic effects.
This breakthrough underscores the potential of integrating traditional Ayurvedic practices with modern medical approaches to improve patient outcomes in chronic conditions like Rheumatoid Arthritis.
Photo Credit: X
